An early-stage trial of Novavax's candidate SARS-CoV-2 vaccine has exhibited promising results, the Sydney Morning Herald reports.
An early-stage trial of Novavax's candidate SARS-CoV-2 vaccine has exhibited promising results, the Sydney Morning Herald reports.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.